• Thumbnail for Astellas Pharma
    Astellas Pharma Inc. (アステラス製薬株式会社, Asuterasu Seiyaku Kabushiki-gaisha) is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from...
    27 KB (2,460 words) - 00:25, 13 September 2024
  • Astellas Institute for Regenerative Medicine is a subsidiary of Astellas Pharma located in Marlborough, Massachusetts, US, developing stem cell therapies...
    10 KB (851 words) - 17:26, 11 September 2024
  • Year Ended March 31, 2021 Annual Report 2021 (PDF) (Report). Astellas. 31 March 2020. "Astellas Pharma Inc. Annual Report 2018" (PDF). www.astellas.com....
    62 KB (2,735 words) - 16:33, 29 August 2024
  • Thumbnail for Fezolinetant
    this source, which is in the public domain. "Astellas to Acquire Ogeda SA" (Press release). Astellas Pharma. Archived from the original on 5 November 2021...
    18 KB (1,348 words) - 00:42, 27 December 2024
  • staphylococcus infections. In 2015, the company announced it would acquire Astellas Pharmas dermatology business for $725 million. In 2018, the company acquired...
    9 KB (834 words) - 07:22, 11 October 2024
  • September 2024. "Astellas' Vyloy (zolbetuximab) Approved in Japan for Treatment of Gastric Cancer" (Press release). Astellas Pharma. 26 March 2024. Archived...
    12 KB (840 words) - 00:40, 27 December 2024
  • Thumbnail for Chūō, Tokyo
    Industries, Denka and Kureha Corporation, three global chemical companies; Astellas Pharma, a global pharmaceutical company; KOSÉ, a personal care and cosmetics...
    30 KB (2,465 words) - 14:34, 24 December 2024
  • Prefecture, Japan Fujisawa, Kanagawa, a city in Kanagawa Prefecture, Japan Astellas Pharma, formed from the merger of Yamanouchi Pharmaceutical Co., Ltd. and...
    348 bytes (78 words) - 06:12, 23 August 2023
  • Thumbnail for Febuxostat
    2009. "Teijin Pharma and Astellas Pharma enter into agreement for marketing rights of TMX-67 in China and Hong Kong". First Word Pharma. 1 April 2010...
    17 KB (1,490 words) - 23:06, 11 November 2024
  • Thumbnail for Conivaptan
    Conivaptan (category Astellas Pharma)
    pharmaceuticals and Fujisawa Pharmaceuticlas merged and were renamed as Astellas’ in 2005. Astellas gained FDA approval for Conivaptan hydrochloride on 29 December...
    8 KB (805 words) - 13:07, 26 July 2024
  • Thumbnail for Tamsulosin
    Tamsulosin (category Astellas Pharma)
    Russia and Iceland, it is marketed under the trade name Omnic by Astellas Pharma Europe. The largest manufacturer of tamsulosin is Synthon BV (the Netherlands)...
    17 KB (1,435 words) - 22:18, 25 December 2024
  • Thumbnail for Tacrolimus
    Tacrolimus (category Astellas Pharma)
    in adults and children. A branded version of the drug is owned by Astellas Pharma, and is sold under the brand name Prograf, given twice daily. A number...
    43 KB (4,357 words) - 14:22, 22 November 2024
  • Thumbnail for Pfizer
    Drug Administration approved enzalutamide, developed by Pfizer and Astellas Pharma for patients with castration-resistant prostate cancer. In August 2018...
    168 KB (14,766 words) - 16:58, 1 January 2025
  • Thumbnail for Ipragliflozin
    (PDF). Astellas Pharma Inc. 31 March 2014. Archived from the original (PDF) on 4 September 2019. Retrieved 12 November 2016. "About Astellas". Astellas Pharma...
    12 KB (1,110 words) - 00:39, 13 September 2024
  • Thumbnail for Regadenoson
    017. PMID 15261132. "CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM)" (PDF). Astellas Pharma US, Inc. 20 November 2024. "Rapiscan EPAR"...
    6 KB (394 words) - 00:09, 10 December 2024
  • Yamanouchi, eponymous founder of Yamanouchi Pharmaceutical Co., now part of Astellas Pharma Don Yamauchi, American chef Edwin M. Yamauchi, historian and biblical...
    2 KB (276 words) - 03:09, 26 February 2024
  • product pipeline includes enfortumab vedotin, being co-developed with Astellas Pharma, tisotumab vedotin, being co-developed with Genmab, SGN-LIV1A, an ADC...
    36 KB (3,161 words) - 13:50, 31 December 2024
  • Thumbnail for Linaclotide
    distribute the drug in Europe to Almirall and had licensed Asian rights to Astellas Pharma. It was approved in the United States and in the European Union in...
    22 KB (1,652 words) - 16:53, 23 December 2024
  • Mirabegron (category Astellas Pharma)
    50mg prolonged-release tablets". electronic Medicines Compendium. Astellas Pharma Ltd. 22 February 2013. Archived from the original on 2 April 2015....
    12 KB (932 words) - 06:55, 30 November 2024
  • Thumbnail for Erlotinib
    Erlotinib (category Astellas Pharma)
    Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. Specifically...
    22 KB (1,993 words) - 23:37, 23 March 2024
  • Thumbnail for Nikkei 225
    7951) Eneos Holdings (TYO: 5020) Idemitsu Kosan Co., Ltd (TYO: 5019) Astellas Pharma Inc. (TYO: 4503) Chugai Pharmaceutical Co., Ltd. (TYO: 4519) Daiichi...
    31 KB (2,534 words) - 19:42, 1 January 2025
  • Thumbnail for Cefdinir
    Cefdinir (category Astellas Pharma)
    and in India as Cednir by Abbott, Kefnir by Glenmark, Cefdair by Xalra Pharma and Cefdiel by Ranbaxy. "Cefdinir Monograph for Professionals". Drugs.com...
    11 KB (881 words) - 18:56, 27 November 2024
  • as Ferring Pharmaceuticals, Ipsen, Takeda Pharmaceutical Company, Astellas Pharma, Sandoz, and Sun Pharmaceutical Industries supply much of the rest...
    142 KB (13,808 words) - 12:42, 31 December 2024
  • solution), a New Treatment for Geographic Atrophy" (Press release). Astellas Pharma Inc. 4 August 2023. Retrieved 25 August 2023 – via PR Newswire. Lyu...
    22 KB (2,663 words) - 12:50, 20 December 2024
  • breakthrough therapy designation. The FDA granted the approval of Padcev to Astellas Pharma US Inc. In July 2021, the FDA approved enfortumab vedotin for adults...
    14 KB (1,039 words) - 01:30, 18 May 2024
  • 2011). "Astellas pulls the plug on darexaban". Pharmatimes. Archived from the original on 13 April 2014. Retrieved 11 April 2014. "Astellas Pharma Inc. Discontinues...
    16 KB (1,525 words) - 21:06, 24 November 2024
  • Thumbnail for Solifenacin
    Solifenacin (category Astellas Pharma)
    granted to Astellas Pharma US, Inc. The international nonproprietary name (INN) is solifenacin. It is manufactured and marketed by Astellas, GlaxoSmithKline...
    17 KB (1,605 words) - 23:03, 22 December 2024
  • Thumbnail for Human betaherpesvirus 5
    vaccination. In one case also congenital CMV was encountered. In 2013, Astellas Pharma started on individuals who received a hematopoietic stem cell transplant...
    58 KB (6,371 words) - 11:09, 24 November 2024
  • Thumbnail for Macular degeneration
    solution), a New Treatment for Geographic Atrophy" (Press release). Astellas Pharma Inc. 4 August 2023. Retrieved 25 August 2023 – via PR Newswire. Lyu...
    92 KB (9,943 words) - 17:13, 21 December 2024
  • Thumbnail for Enzalutamide
    Enzalutamide (category Astellas Pharma)
    1002/cmdc.201000259. PMID 20853390. S2CID 23228778. "Enzalutamide - Astellas Pharma/Medivation - AdisInsight". Archived from the original on 17 July 2018...
    50 KB (4,716 words) - 04:56, 30 December 2024